Back to video list Back to Home Are there any patient that is not suitable for CGRP pathway monoclonal antibody? You may also like Alzheimer's Disease Article Addressing challenges of dosage and administration in the development of disease-modifying therapy Alzheimer's Disease Article Taking a closer look at tau Alzheimer's Disease Article How beneficial is cholinesterase inhibition and for whom? Migraine Satellite symposium Article Tackling the pervasive impact of migraine